Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains

Nutrition

Volumn 26, Issue 11-12, 2010, Pages 1195-1200

  Lin, Shyh Mirn ^a   Wang, Shih Wei ^a   Ho, Su Chen ^b   Tang, Ya Li ^a  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b YUANPEI UNIVERSITY   (Taiwan)

Author keywords

Antioxidation; Brain; EGCG; MAO B; Monoamine oxidase B; Polyphenol

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ASPARTATE AMINOTRANSFERASE; EPIGALLOCATECHIN GALLATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; URIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FOOD INTAKE; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUPPLEMENTATION; TEA; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

AGING; ANIMALS; ANTIOXIDANTS; BRAIN; CATECHIN; DIETARY SUPPLEMENTS; LIPID PEROXIDATION; LIVER; MALE; MONOAMINE OXIDASE; NEURODEGENERATIVE DISEASES; NEURONS; ORGAN SPECIFICITY; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS; TEA; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS;

EID: 77957761039     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.11.022     Document Type: Article

References (42)

1. Weyler W., Hsu Y.P., Breakefield X.O. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 1990, 47:391-417.
2. Strolin Benedetti M., Dostert P. Monoamine oxidase, brain ageing and degenerative diseases. Biochem Pharmacol 1989, 38:555-561.
3. Jossan S.S., Gillberg P.G., d'Argy R., Aquilonius S.M., Langstrom B., Halldin C., et al. Quantitative localization of human brain monoamine oxidase B by large section autoradiography using L-[3H]deprenyl. Brain Res 1991, 547:69-76.
4. Nicotra A., Pierucci F., Parvez H., Senatori O. Monoamine oxidase expression during development and aging. Neurotoxicology 2004, 25:155-165.
5. Saura J., Luque J.M., Cesura A.M., Da Prada M., Chan-Palay V., Huber G., et al. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 1994, 62:15-30.
6. Sherif F., Gottfries C.G., Alafuzoff I., Oreland L. Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease. J Neural Transm Park Dis Dement Sect 1992, 4:227-240.
7. Knoll J. The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases. J Neural Transm Suppl 1993, 40:69-91.
8. Nagatsu T., Sawada M. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells. J Neural Transm Suppl 2006, 71:53-65.
9. Yamada M., Yasuhara H. Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology 2004, 25:215-221.
10. Williamson G., Holst B. Dietary reference intake (DRI) value for dietary polyphenols: are we heading in the right direction?. Br J Nutr 2008, 99(Suppl 3):S55-S58.
11. Goto T., Yoshida Y., Kiso M., Nagashima H. Simultaneous analysis of individual catechins and caffeine in green tea. J Chromatog A 1996, 749:295-299.
12. Nagle D.G., Ferreira D., Zhou Y.D. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 2006, 67:1849-1855.
13. Mandel S., Youdim M.B. Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 2004, 37:304-317.
14. Weinreb O., Mandel S., Amit T., Youdim M.B. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J Nutr Biochem 2004, 15:506-516.
15. Levites Y., Weinreb O., Maor G., Youdim M.B., Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 2001, 78:1073-1082.
16. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001, 65:135-172.
17. Mazzio E.A., Harris N., Soliman K.F. Food constituents attenuate monoamine oxidase activity and peroxide levels in C6 astrocyte cells. Planta Med 1998, 64:603-606.
18. Cao G., Alessio H.M., Cutler R.G. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 1993, 14:303-311.
19. Niehaus W.G., Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968, 6:126-130.
20. McEwen C.M., Cohen J.D. An amine oxidase in normal human serum. J Lab Clin Med 1963, 62:766-776.
21. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
22. Tang Y.L., Wang S.W., Lin S.M. Both inorganic and organic selenium supplements can decrease brain monoamine oxidase B enzyme activity in adult rats. Br J Nutr 2008, 100:660-665.
23. Devika P.T. Stanely Mainzen Prince P. Protective effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: a histopathological study. Biomed Pharmacother 2008, 62:701-708.
24. Aucamp J., Gaspar A., Hara Y., Apostolides Z. Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis). Anticancer Res 1997, 17:4381-4385.
25. Lin J.K., Chen P.C., Ho C.T., Lin-Shiau S.Y. Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,3'-digallate, (-)-epigallocatechin-3-gallate, and propyl gallate. J Agric Food Chem 2000, 48:2736-2743.
26. Seeram N.P., Henning S.M., Niu Y., Lee R., Scheuller H.S., Heber D. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. J Agric Food Chem 2006, 54:1599-1603.
27. Singh M., Arseneault M., Sanderson T., Murthy V., Ramassamy C. Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J Agric Food Chem 2008, 56:4855-4873.
28. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res 2005, 49:7-30.
29. Haque A.M., Hashimoto M., Katakura M., Tanabe Y., Hara Y., Shido O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 2006, 136:1043-1047.
30. Leaden P.J., Catala A. Melatonin and N-acetyl serotonin inhibit selectively enzymatic and non-enzymatic lipid peroxidation of rat liver microsomes. Prostaglandins Leukot Essent Fatty Acids 2007, 77:29-35.
31. Senthil Kumaran V., Arulmathi K., Srividhya R., Kalaiselvi P. Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats. Exp Gerontol 2008, 43:176-183.
32. Tanaka M., Baba Y., Kataoka Y., Kinbara N., Sagesaka Y.M., Kakuda T., et al. Effects of (-)-epigallocatechin gallate in liver of an animal model of combined (physical and mental) fatigue. Nutrition 2008, 24:599-603.
33. Srividhya R., Jyothilakshmi V., Arulmathi K., Senthilkumaran V., Kalaiselvi P. Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (-)-epigallocatechin-3-gallate. Int J Dev Neurosci 2008, 26:217-223.
34. Raciti G., Mazzone P., Raudino A., Mazzone G., Cambria A. Inhibition of rat liver mitochondrial monoamine oxidase by hydrazine-thiazole derivatives: structure-activity relationships. Bioorg Med Chem 1995, 3:1485-1491.
35. Suganuma M., Okabe S., Oniyama M., Tada Y., Ito H., Fujiki H. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998, 19:1771-1776.
36. Mata-Bilbao Mde L., Andres-Lacueva C., Roura E., Jauregui O., Escribano E., Torre C., et al. Absorption and pharmacokinetics of green tea catechins in beagles. Br J Nutr 2008, 100:496-502.
37. Lin L.C., Wang M.N., Tseng T.Y., Sung J.S., Tsai T.H. Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. J Agric Food Chem 2007, 55:1517-1524.
38. Marlatt M.W., Lucassen P.J., Perry G., Smith M.A., Zhu X. Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. J Alzheimers Dis 2008, 15:199-210.
39. Intra J., Kuo S.M. Physiological levels of tea catechins increase cellular lipid antioxidant activity of vitamin C and vitamin E in human intestinal caco-2 cells. Chem Biol Interact 2007, 169:91-99.
40. Sang S., Yang I., Buckley B., Ho C.T., Yang C.S. Autoxidative quinone formation in vitro and metabolite formation in vivo from tea polyphenol (-)-epigallocatechin-3-gallate: studied by real-time mass spectrometry combined with tandem mass ion mapping. Free Radic Biol Med 2007, 43:362-371.
41. Thomas B., Saravanan K.S., Mohanakumar K.P. In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole. Neurochem Int 2008, 52:990-1001.
42. Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. J Nutr 1977, 107:1340-1348. American Institute of Nutrition.